Cell line · CVCL_3814
WPMY-1
Transformed cell line, Homo sapiens. 12 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. WPMY-1. Cell lines, record CVCL_3814. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_3814
On this page
Cell line
As Cellosaurus gives it.
- Name
- WPMY-1
- Accession
- CVCL_3814
- RRID
- RRID:CVCL_3814
- Synonyms
- WPMY1, WPM-Y.1
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 54Y
- Category
- Transformed cell line
- Derived from
- Prostate, stroma (in situ)
- Cell type
- Stromal cell of prostate
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers12
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Prostatic fibroblast reprogramming by Interleukin-30 activates prostate cancer metastasis programs. | Mol Biomed | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Spatial and single-cell transcriptomics reveal a HIF-1α/NF-κB-driven hypoxia-induced senescence axis in BPH epithelium. | Int J Biol Sci | 2026 | Its Methods give the RRID and name the line | PubMed | |
| CAF-mediated regulation of prostate cancer stem cell stemness via the Wnt/β-catenin and SDF-1/CXCR4 pathways in castration-resistant prostate cancer. | Front Cell Dev Biol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Development of an orally bioavailable CDK12/13 degrader and induction of synthetic lethality with AKT pathway inhibition. | Cell Rep Med | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Effects of carvedilol on human prostate tissue contractility and stromal cell growth pointing to potential clinical implications. | Pharmacol Rep | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Immunosuppressive role of BDNF in therapy-induced neuroendocrine prostate cancer. | Mol Oncol | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003. | Front Pharmacol | 2023 | Its Methods give the RRID and name the line | PubMed | |
| The lactate-NAD+ axis activates cancer-associated fibroblasts by downregulating p62. | Cell Rep | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Castration-Induced Downregulation of SPARC in Stromal Cells Drives Neuroendocrine Differentiation of Prostate Cancer. | Cancer Res | 2021 | Its Methods give the RRID and name the line | PubMed | |
| IL-27/IL-27RA signaling may modulate inflammation and progression of benign prostatic hyperplasia via suppressing the LPS/TLR4 pathway. | Transl Cancer Res | 2020 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 12
See all 12 papersRelatives2
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | HyCyte WPMY-1 KO-hHIF1A | CVCL_F1V0 | Cell lines | |
| From the same person | RWPE-1 | CVCL_3791 | Cell lines |
Cell banks3
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_3814
GET https://conductscience.org/api/cell-lines/v1/CVCL_3814/problems